Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05RQF
|
|||
| Drug Name |
Benzoxazole derivative 1
|
|||
| Synonyms |
PMID26413912-Compound-83
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
RENOVIS, INC. KAUB, Carl GOWLUGARI, Sumithra KINCAID, John JOHNSON, Russell, James O'MAHONY, Donogh, John Roger ESTIARTE-MARTINEZ, Maria, de los Angeles DUNCTON, Matthew
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C25H21N3O
|
|||
| Canonical SMILES |
CCN1C=CC2=C1C=CC(=C2)C3=CC4=C(C=C3)OC(=N4)N5CC6=CC=CC=C6C5
|
|||
| InChI |
1S/C25H21N3O/c1-2-27-12-11-19-13-17(7-9-23(19)27)18-8-10-24-22(14-18)26-25(29-24)28-15-20-5-3-4-6-21(20)16-28/h3-14H,2,15-16H2,1H3
|
|||
| InChIKey |
JRHOETSWOCHDIA-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fatty acid amide hydrolase (FAAH) | Target's Patent Info | [1] | |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.